M Falconi
Overview
Explore the profile of M Falconi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
256
Citations
5657
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scognamiglio F, Pizzolitto C, Romano M, Teti G, Zara S, Conz M, et al.
Biomater Adv
. 2024 Apr;
160:213849.
PMID: 38599041
Spheroids derived from human mesenchymal stem cells (hMSCs) are of limited use for cartilage regeneration, as the viability of the cells progressively decreases during the period required for chondrogenic differentiation...
2.
Redegalli M, Schiavo Lena M, Cangi M, Smart C, Mori M, Fiorino C, et al.
Ann Surg Oncol
. 2022 Mar;
29(6):3492-3502.
PMID: 35230580
Background: Limited information is available on the relevant prognostic variables after surgery for patients with pancreatic ductal adenocarcinoma (PDAC) subjected to neoadjuvant chemotherapy (NACT). NACT is known to induce a...
3.
Mapelli P, Bezzi C, Palumbo D, Canevari C, Ghezzo S, Samanes Gajate A, et al.
Eur J Nucl Med Mol Imaging
. 2022 Feb;
49(7):2352-2363.
PMID: 35156146
Purpose: To explore the role of fully hybrid Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine tumours (PanNETs) undergoing surgery. Methods: One...
4.
Andreasi V, Partelli S, Manzoni M, Muffatti F, di Filippo L, Crippa S, et al.
J Endocrinol Invest
. 2022 Feb;
45(6):1209-1217.
PMID: 35122631
Purpose: No single reliable biomarker is available for nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs). Vasostatin-1 (VS-1), the N-terminal fragment of chromogranin A (CgA), seems to be a more accurate biomarker compared...
5.
Andreasi V, Ricci C, Partelli S, Guarneri G, Ingaldi C, Muffatti F, et al.
J Endocrinol Invest
. 2021 Nov;
45(4):705-718.
PMID: 34773595
Purpose: Patients submitted to curative surgery for non-functioning pancreatic neuroendocrine neoplasms (NF-PanNENs) exhibit a variable risk of disease relapse. Aims of this meta-analysis were to estimate the rate of disease...
6.
Modlin I, Kidd M, Falconi M, Filosso P, Frilling A, Malczewska A, et al.
Ann Oncol
. 2021 Aug;
32(11):1425-1433.
PMID: 34390828
Background: Biomarkers are key tools in cancer management. In neuroendocrine tumors (NETs), Chromogranin A (CgA) was considered acceptable as a biomarker. We compared the clinical efficacy of a multigenomic blood...
7.
Marchegiani G, Andrianello S, Crippa S, Pollini T, Belfiori G, Gozzini L, et al.
Br J Surg
. 2021 Jun;
108(9):1097-1104.
PMID: 34059873
Background: Despite the low malignant potential of pancreatic mucinous cystic neoplasms (MCNs), surgery is still performed. The aim of this pragmatic study was to assess the outcome of surgery and...
8.
Bezzi C, Mapelli P, Presotto L, Neri I, Scifo P, Savi A, et al.
Eur J Nucl Med Mol Imaging
. 2021 Apr;
48(12):4002-4015.
PMID: 33835220
Purpose: To present the state-of-art of radiomics in the context of pancreatic neuroendocrine tumors (PanNETs), with a focus on the methodological and technical approaches used, to support the search of...
9.
Ricci C, Partelli S, Landoni L, Rinzivillo M, Ingaldi C, Andreasi V, et al.
Br J Surg
. 2021 Mar;
108(7):811-816.
PMID: 33724300
Background: Outcomes after surgery for sporadic pancreatic neuroendocrine neoplasms (Pan-NENs) were evaluated. Methods: This multicentre study included patients who underwent radical pancreatic resection for sporadic non-functioning Pan-NENs. In survival analysis,...
10.
Rossi R, Milanetto A, Andreasi V, Campana D, Coppa J, Nappo G, et al.
J Endocrinol Invest
. 2021 Mar;
44(10):2227-2234.
PMID: 33651317
Purpose: Pretreatment staging is the milestone for planning either surgical or endoscopic treatment in duodenal neuroendocrine neoplasms (dNENs). Herein, a series of surgically treated dNEN patients was evaluated to assess...